碩士 / 國立高雄大學 / 經濟管理研究所 / 95 / After completion of human genome project (HGP) in 2003, biology went into “post-genome era.” Many Asian countries have markedly different approaches to craving out a niche in the Asian biotech arena. Taiwan also proposed the “Two Trillions, Twin Stars plan” to advance biotech industry. Taiwanese biotech firms not only amplify actively in the domestic market, but also execute FDI in order to enhance their competitiveness and efficiency. This study applies the slack-based measure model to analyze hoe FDI affect the operating efficiency of Taiwanese biotech firms. We further decompose the technical efficiency into three components: Pure technical efficiency, scale efficiency, and mixed efficiency. In addition, the super efficiency index is used to rank Taiwanese biotech firms
The empirical results, based on 73 Taiwanese biotech firms for the period 2003�{2005, indicate that FDI can effectively increase the efficiency of Taiwanese biotech firms. This may result from the fact that there are 84 percent of them operating on the extent of increasing returns to scale, and FDI might be adequately enhancing the scale. Other findings are: (1) On average, Taiwanese biotech firms could increase their technical efficiencies by 83.94 percent if all firms operated on the production frontier; (2) If we omit the non-radial input slacks, we may overestimate technical efficiency about 20.17 percent; (3) the average scale efficiency of listed companies at stock exchange market are higher than those at over-the-counter market, while the pure technical efficiency and the mixed efficiency reveal the opposite pattern.
| Identifer | oai:union.ndltd.org:TW/095NUK05771012 |
| Date | January 2007 |
| Creators | Song-chiao Hsia, 夏松喬 |
| Contributors | Yang Li, 李揚 |
| Source Sets | National Digital Library of Theses and Dissertations in Taiwan |
| Language | zh-TW |
| Detected Language | English |
| Type | 學位論文 ; thesis |
| Format | 63 |
Page generated in 0.0105 seconds